We are pleased to announce that Ruchun Ji, partner in Sidley’s Palo Alto office, has moved to the firm’s Shanghai office as of September 1. Ruchun brings years of experience counseling emerging and innovative life sciences, healthcare and technology industries throughout their lifecycle. He focuses primarily on mergers and acquisitions, private equity and venture capital financings, joint ventures and public securities offerings. He regularly represents corporations, private equity sponsors and venture capital investors in the United States, China, and other Asia countries in domestic and cross-border investments, divestitures and acquisitions, both inbound and outbound.
Ruchun’s experience in the life sciences industry and ability to better service life sciences clients in China will strengthen Sidley’s already strong presence in Asia. Scott Bass, head of Sidley’s Global Life Sciences practice, states, “We are delighted to announce Ruchun’s move to the Shanghai office. He will be instrumental in cross-border corporate needs for our life sciences client base.”
Li Lei, Office Managing Partner of Sidley in Beijing and Shanghai, said, “Ruchun has a reputation in the market for not only commercial savvy but also the highest caliber of client service. His relocation will greatly enhance our on-the-ground corporate offerings.”
In 2007, Sidley became the first international law firm to establish a standalone, comprehensive food and drug regulatory practice in China. It is one of very few law firms that has recognized capabilities in life science across a number of various disciplines.
Ruchun recently co-authored with partner Tom Duley the article "Crossing the International Dateline: US-China Life Sciences Transactions”.